MarketScreener Editorial Features Genmab A/S
Equities
GMAB
DK0010272202
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,536.00 DKK | -1.32% | +0.49% | -28.72% |
09/12 | Genmab's Potential Leukemia Treatment Shows Overall Response Rate of 61% in Phase 1/2 Trial | MT |
09/12 | Genmab's Chronic Lymphocytic Leukemia Antibody Shows High Response Rates | MT |
MarketScreener Editorial Features
New entries in MarketScreener's Europe portfolio | December 08, 2023 at 04:32 pm IST |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- MarketScreener Editorial Features
MarketScreener is also available in this country: United States.
Switch edition